Consultative Proteomics has the expertise and the capabilities to test more for than 60 protein analytes in our CLIA-certified morphoproteomics service laboratory. This means that a patient’s molecular tumor signature may include uncommon proteins that are key to treatment planning in consultation with the patient’s doctor.

Note that this list is for reference only and may change without notice. The actual protein analytes used in a Consultative Proteomics Report are chosen solely based upon the expert opinion of the consulting pathologist. For more information, please contact our Coordinator, Ms. Bheravi Patel, at 713-500-5309. E-mail: Bheravi.Patel@uth.tmc.edu.